BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33685601)

  • 1. Modification of Cas9, gRNA and PAM: Key to further regulate genome editing and its applications.
    Gupta R; Gupta D; Ahmed KT; Dey D; Singh R; Swarnakar S; Ravichandiran V; Roy S; Ghosh D
    Prog Mol Biol Transl Sci; 2021; 178():85-98. PubMed ID: 33685601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
    Moreb EA; Hutmacher M; Lynch MD
    CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
    Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
    Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
    Mekler V; Kuznedelov K; Severinov K
    J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An introduction and use of the CRISPR-Cas systems.
    Singh V
    Prog Mol Biol Transl Sci; 2021; 179():1-10. PubMed ID: 33785173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method to convert mRNA into a gRNA library for CRISPR/Cas9 editing of any organism.
    Arakawa H
    Sci Adv; 2016 Aug; 2(8):e1600699. PubMed ID: 27574704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
    Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
    Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects].
    Xie SS; Zhang Y; Zhang LS; Li GL; Zhao CZ; Ni P; Zhao SH
    Yi Chuan; 2015 Nov; 37(11):1125-36. PubMed ID: 26582526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in precise regulation of CRISPR/Cas9 gene editing technology.
    Cao JX; Wang YL; Wang ZX
    Yi Chuan; 2020 Dec; 42(12):1168-1177. PubMed ID: 33509781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity.
    Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z
    Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.
    Wang F; Hao Y; Li Q; Li J; Zhang H; Zhang X; Wang L; Bustamante C; Fan C
    Sci Adv; 2020 May; 6(19):eaay9948. PubMed ID: 32494703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.